Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Metastatic Castration-resistant Prostate Cancer (mCRPC) × abiraterone × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Neoplasm Metastasis 2 Metastatic Hormone-Sensitive Prostate Cance 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Advanced Prostate Carcinoma 1

Interventions

radium Ra 223 dichloride 1 enzalutamide 1 abiraterone 1 Radium-223 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03896984 2021-12-29

PHENIX

Bayer

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡